Indefinite-Lived Research and Development Assets
Mondelez International Indefinite-Lived Research and Development Assets decreased by 0.4% to $18.58B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $18.08B to $18.58B. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows relatively stable performance with a 1.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.62B | $17.38B | $17.30B | $17.83B | $17.39B | $18.22B | $18.41B | $18.53B | $18.60B | $18.29B | $18.67B | $18.48B | $18.33B | $18.43B | $17.77B | $18.08B | $18.69B | $18.60B | $18.65B | $18.58B |
| QoQ Change | — | -1.3% | -0.5% | +3.1% | -2.4% | +4.8% | +1.0% | +0.6% | +0.4% | -1.7% | +2.1% | -1.0% | -0.8% | +0.6% | -3.6% | +1.8% | +3.4% | -0.5% | +0.2% | -0.4% |
| YoY Change | — | — | — | — | -1.3% | +4.9% | +6.4% | +3.9% | +6.9% | +0.4% | +1.4% | -0.3% | -1.5% | +0.8% | -4.8% | -2.2% | +2.0% | +0.9% | +4.9% | +2.7% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Mondelez International's indefinite-lived research and development assets?
- Mondelez International (MDLZ) reported indefinite-lived research and development assets of $18.58B in Q1 2026.
- How has Mondelez International's indefinite-lived research and development assets changed year-over-year?
- Mondelez International's indefinite-lived research and development assets increased by 2.7% year-over-year, from $18.08B to $18.58B.
- What is the long-term trend for Mondelez International's indefinite-lived research and development assets?
- Over 5 years (2020 to 2025), Mondelez International's indefinite-lived research and development assets has grown at a 1.3% compound annual growth rate (CAGR), from $17.49B to $18.65B.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.